Turbine
Focus: Turbine develops simulated cell technology for pharmaceutical R&D, enabling drug discovery and testing through computational biology platforms. The company operates as a specialized technology provider to the broader pharma ecosystem.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Open Jobs
9-2 this month
Stable — net -2 jobs in 30d
0 added, 2 removed. Backfill posture.
Should You Work at Turbine?
AI assessmentHigh-risk, high-upside opportunity for technologists and scientists willing to bet on platform adoption in a pre-revenue biotech, but financial sustainability remains unproven.
Why Work Here
- Early-stage deep tech company with specialized niche (simulated cell technology) offering ground-floor opportunity to shape platform adoption across pharma
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Turbine
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.